EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Corrigendum to “Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis” [Clin. Immunol. 288 (2026) 110766]

Darin T Okuda, Benjamin J Anderson, Sophia M Taylor, Morgan C Jones-McCreary, Katy W Burgess, Crystal M Wright, Jose R Santoyo, Peter V Sguigna, Olaf Stüve, Diem H Tran, David Y Light, Tatum M Moog und 1 weitere

Clinical Immunology · 2026-09 · 110778

DOI: 10.1016/j.clim.2026.110778 ↗

Kurz gefasst

Korrektur in der Zeitschrift Clinical Immunology, 2026-09. Verfasst von Darin T Okuda und 12 weiteren Autor:innen. Beteiligte Einrichtung: The University of Texas Southwestern Medical Center, Department of Neurology, Neuroinnovation Program, Multiple Sclerosis & Neuroimmunology Imaging P…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • The University of Texas Southwestern Medical Center, Department of Neurology, Neuroinnovation Program, Multiple Sclerosis & Neuroimmunology Imaging Program, Dallas, TX, USA; The University of Texas Southwestern Medical…
  • Valisure, New Haven, CT, USA; Long Island University, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Brooklyn, NY, USA.
  • The University of Texas Southwestern Medical Center School of Medicine, Dallas, TX, USA.

Zitieren

APA

Okuda, D. T., Anderson, B. J., Taylor, S. M., Jones-McCreary, M. C., Burgess, K. W., Wright, C. M., Santoyo, J. R., Sguigna, P. V., Stüve, O., Tran, D. H., Light, D. Y., Moog, T. M., & Punnen, T. G. (2026). Corrigendum to “Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis” [Clin. Immunol. 288 (2026) 110766]. Clinical Immunology, 110778. https://doi.org/10.1016/j.clim.2026.110778

Vancouver

Okuda DT, Anderson BJ, Taylor SM, Jones-McCreary MC, Burgess KW, Wright CM, et al. Corrigendum to “Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis” [Clin. Immunol. 288 (2026) 110766]. Clinical Immunology. 2026:110778. doi:10.1016/j.clim.2026.110778

BibTeX
@article{Okuda2026,
  author = {Okuda, Darin T and Anderson, Benjamin J and Taylor, Sophia M and Jones-McCreary, Morgan C and Burgess, Katy W and Wright, Crystal M and Santoyo, Jose R and Sguigna, Peter V and Stüve, Olaf and Tran, Diem H and Light, David Y and Moog, Tatum M and Punnen, Tom G},
  title = {Corrigendum to “Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis” [Clin. Immunol. 288 (2026) 110766]},
  journal = {Clinical Immunology},
  year = {2026},
  pages = {110778},
  doi = {10.1016/j.clim.2026.110778}
}
Kostenlos starten →